Follow-up report confirms benefits of finasteride therapy

08/26/2013 | AAFP News Now

A New England Journal of Medicine report said follow-up data from a study of finasteride that ended in 2003 showed it can reduce the overall risk of prostate cancer in men who were regularly screened for the disease. The study update confirmed results of the Prostate Cancer Prevention Trial and found that an increased risk of high-grade cancer associated with use of the drug did not have an effect on mortality.

View Full Article in:

AAFP News Now

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director of Behavioral Health Operations
Meridian Health Plan
Detroit, MI
Medical Director
PacificSource
Bend, OR
Clinical Appeals RN
MJHS
Brooklyn, NY
Director of Clinical Operations
Meridian Health Plan
Detroit, MI
Sr. Director, Regulatory Compliance Intelligence and Outreach
Johnson & Johnson
New Brunswick, NJ